Filana Therapeutics announces publication in Cells of promising preclinical findings for simufilam in TSC2-deficient cells
FLNA•Filana Therapeutics announced publication in Cells of preclinical findings for simufilam in TSC2-deficient cells.
1. Preclinical findings published
Filana Therapeutics announced publication in Cells of preclinical findings for simufilam in TSC2-deficient cells.
